Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
+56,25% in 5 Tagen: Genialer Schachzug - diese Übernahme verändert alles
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 895308 | ISIN: US50540R4092 | Ticker-Symbol: LAB
Düsseldorf
06.05.24
16:30 Uhr
186,00 Euro
0,00
0,00 %
Branche
Sonstige Technologie
Aktienmarkt
S&P 500
1-Jahres-Chart
LABORATORY CORPORATION OF AMERICA HOLDINGS Chart 1 Jahr
5-Tage-Chart
LABORATORY CORPORATION OF AMERICA HOLDINGS 5-Tage-Chart
RealtimeGeldBriefZeit
185,00186,0019:07
185,00186,0017:56

Aktuelle News zur LABORATORY CORP OF AMERICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiLaboratory Corporation of America Holdings (LH) Q1 2024 Earnings Call Transcript2
DiLABORATORY CORP OF AMERICA HOLDINGS - 10-Q, Quarterly Report2
29.04.Labcorp nets companion diagnostic approval for Pfizer's hemophilia B gene therapy Beqvez4
29.04.Quest Diagnostics, LabCorp climb following FDA testing oversight rule3
29.04.Labcorp: FDA Approves NAbCyte Companion Diagnostic241NEW YORK CITY (dpa-AFX) - Labcorp (LH) announced the FDA has approved its nAbCyte Anti-AAVRh74var HB-FE Assay, a companion diagnostic to determine patient eligibility for treatment with BEQVEZ...
► Artikel lesen
29.04.Labcorp's companion diagnostic approved for use with Pfizer's hemophilia B gene therapy5
29.04.Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B526Assay expands company's leadership in precision medicine and cell and gene therapy BURLINGTON, N.C., April 29, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive...
► Artikel lesen
28.04.Labcorp Makes Another Acquisition, Plucking Invitae Assets From Bankruptcy Auction9
26.04.Analyst Ratings For Laboratory Corp2
26.04.Labcorp picks up Invitae portfolio for $239M in bankruptcy sale9
25.04.Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal6
25.04.Laboratory Corporation Of America Holdings Q1 Income Climbs, But Misses Estimates182WASHINGTON (dpa-AFX) - Laboratory Corporation Of America Holdings (LH) announced a profit for its first quarter that increased from the same period last year but missed the Street estimates.The...
► Artikel lesen
25.04.Laboratory Corporation of America Holdings reports results for the quarter ended in March - Earnings Summary3
25.04.Labcorp (LH) Tops Q1 Earnings Estimates, Raises 2024 EPS View3
25.04.ROUNDUP: Labcorp Narrows FY24 Outlook Range166WASHINGTON (dpa-AFX) - While reporting financial results for the first quarter on Thursday, life sciences company Labcorp (LH) narrowed adjusted earnings and revenue growth guidance range for...
► Artikel lesen
25.04.Laboratory Corporation Of America Holdings Q1 Income Climbs, but misses estimates182WASHINGTON (dpa-AFX) - Laboratory Corporation Of America Holdings (LH) announced a profit for its first quarter that increased from the same period last year but missed the Street estimates.The...
► Artikel lesen
25.04.Labcorp shares drop despite Q1 earnings beat3
25.04.Labcorp beats quarterly estimates on strong testing demand4
25.04.LABORATORY CORP OF AMERICA HOLDINGS - 8-K, Current Report2
25.04.Laboratory Corporation of America Holdings: Labcorp Announces 2024 First Quarter Results199Updates Full-Year Guidance Results from Continuing Operations for first quarter 2024 versus last year: Revenue: $3.18 billion versus $3.04 billion or up 4.6% | Base Business grew 6.7% Diluted EPS:...
► Artikel lesen
Seite:  Weiter >>
116 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1